NEW YORK (Reuters Health) – Randomized trials have shown a survival benefit to using drug-eluting stents (DES) rather than bare-metal stents (BMS) in heart disease patients. Now, the…
NEW YORK (Reuters Health) – In the treatment of lower urinary tract symptoms in men, extended-release oxybutynin plus tamsulosin is more effective than tamsulosin alone and just as…
NEW YORK (Reuters Health) – Adults with subclinical hypothyroidism are at increased risk for heart failure and for changes in cardiac function, new research suggests. Subclinical hyperthyroidism, by…
NEW YORK (Reuters Health) – The results of a randomized trial suggest that statins may be a useful treatment for Raynaud’s phenomenon and digital ulcers that can accompany…
NEW YORK (Reuters Health) – The results of a new study indicate that the intradermal vaccination route offers greater protection against influenza than the standard intramuscular route in…
NEW YORK (Reuters Health) – Beta-adrenergic receptor antagonists are no more effective than other medications used for primary prevention of heart failure in patients with hypertension, according to…
NEW YORK (Reuters Health) – If an initial screening colonoscopy indicates no colorectal neoplasia, the odds that a malignancy will develop in the next 5 years is “extremely…
NEW YORK (Reuters Health) – Exposure to bisphenol A (BPA), a chemical used in the resins that line food and beverage containers and in the production of polycarbonate…
NEW YORK (Reuters Health) – Treatment with the phosphodiesterase inhibitor pentoxifylline can significantly reduce proteinuria in patients with diabetic and other forms of chronic kidney disease, according to…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…
